Search

Your search keyword '"K. Karasawa"' showing total 28 results
Start Over Author "K. Karasawa" Topic medicine
28 results on '"K. Karasawa"'

1. DIALYSIS CARDIOVASCULAR COMPLICATIONS 1

Author

D. C. Wheeler, S. Abdalla, G. Chertow, P. Parfrey, C. Herzog, I. Mikolasevic, S. Racki, V. Lukenda, S. Milic, B. Devcic, L. Orlic, M. M. Suttorp, T. Hoekstra, G. Ocak, A. T. N. Van Diepen, I. Ott, M. Mittelman, T. J. Rabelink, R. T. Krediet, F. W. Dekker, S. Simone, M. P. S. Dell'Oglio, M. Ciccone, R. Corciulo, G. Castellano, C. Balestra, G. Grandaliano, L. Gesualdo, G. Pertosa, M. Nishida, M. Ando, K. Karasawa, Y. Iwamoto, K. Tsuchiya, K. Nitta, M. Krzanowski, K. Janda, M. Gajda, P. Dumnicka, D. Fedak, G. Lis, P. Ja kowski, J. A. Litwin, W. Su owicz, G. R. Freitas, V. B. Silva, H. Abensur, C. Luders, B. J. Pereira, M. C. Castro, R. B. Oliverira, R. M. Moyses, R. M. Elias, B. C. Silva, H. Tekce, S. Ozturk, G. Aktas, B. Kin Tekce, A. Erdem, M. Ozyasar, T. Taslamacioglu Duman, M. Yazici, A. Kirkpantur, M. M. Balci, A. Turkvatan, B. Afsar, M. Alkis, F. Mandiroglu, L. Voroneanu, D. Siriopol, I. Nistor, M. Apetrii, S. Hogas, M. Onofriescu, A. Covic, W. S. An, S. E. Kim, Y. K. Son, Y. J. Oh, S. Gelev, S. Toshev, L. Trajceska, G. Selim, P. Dzekova, A. Shikole, J. Park, J. S. Lee, E.-S. Shin, S. H. Ann, S.-J. Kim, H. C. Chung, W. Sulowicz, U. Elewa, W. Bichari, K. Abo-Seif, S. Seferi, M. Rroji, E. Likaj, N. Spahia, M. Barbullushi, N. Thereska, C. M. Kopecky, B. Genser, W. Maerz, C. Wanner, M. D. Saemann, T. Weichhart, S. Sezer, B. Gurlek Demirci, E. Tutal, Z. Bal, M. Erkmen Uyar, F. N. Ozdemir Acar, B. Macunluoglu, A. Atakan, E. Ari Bakir, P. Georgianos, P. A. Sarafidis, D. N. Stamatiadis, V. Liakopoulos, P. E. Zebekakis, A. Papagianni, A. N. Lasaridis, N. Eftimovska - Otovic, E. Babalj-Banskolieva, S. Kostadinska-Bogdanoska, R. Grozdanovski, M. Aono, Y. Sato, M. El Amrani, M. Asserraji, M. Benyahia, Y.-K. Lee, S. R. Choi, A. Cho, J.-K. Kim, M.-J. Choi, S. J. Kim, J.-W. Yoon, J.-R. Koo, H. J. Kim, J.-W. Noh, H. Inagaki, N. Yokota, S. Chiyotanda, K. Fukami, S. Fujimoto, Z. Kendi Celebi, S. Kutlay, S. Sengul, G. Nergizoglu, S. Erturk, K. Ates, K. A. Vishnevskii, A. S. Rumyantsev, A. Y. Zemchenkov, A. V. Smirnov, B. Reinhardt, R. Knaup, V. Esteve Simo, J. Carneiro Oliveira, F. Moreno Guzman, M. Fulquet Nicolas, M. Pou Potau, A. Saurina Sole, V. Duarte Gallego, M. Ramirez De Arellano Serna, K. Turkmen, L. Demirtas, E. M. Akbas, E. M. Bakirci, M. Buyuklu, A. Timuroglu, P. I. Georgianos, A. Karpetas, T. Taira, K. Nohtomi, T. Takemura, T. Chiba, T. Hirano, C.-T. Chang, C.-C. Huang, C.-J. Chen, A. Mohamed, H. Kanai, Y. Tamura, Y. Kaizu, A. Kali, O. Yayar, B. Erdogan, B. Eser, Z. Ercan, M. Buyukbakkal, O. Merhametsiz, A. Haspulat, T. Yildirim, B. Bozkurt, M. D. Ayli, D. Gokustun, A. Markaki, M. Grammatikopoulou, G. Fragkiadakis, K. Stylianou, M. Venyhaki, V. Chatzi, O. Stojceva-Taneva, L. Tozija, P. Dzekova-Vidimliski, Z. Petronievic, A. Sikole, V. Moyseyenko, T. Nykula, R. T. Fernandes, D. V. Barreto, G. G. C. Rodrigues, A. Misael, C. T. Branco-Martins, and F. C. Barreto

Subjects
Transplantation, medicine.medical_specialty, Nephrology, business.industry, medicine, Intensive care medicine, business, Dialysis (biochemistry)
Published
2014

2. MEDICAL RADIATION THERAPIES

Author

I. Ahmed, A. Biswas, S. Krishnamurthy, P. Julka, G. Rath, M. Back, D. Huang, C. Gzell, J. Chen, M. Kastelan, P. Gaur, H. Wheeler, S. N. Badiyan, C. G. Robinson, J. R. Simpson, D. D. Tran, K. M. Rich, J. L. Dowling, M. R. Chicoine, E. C. Leuthardt, A. H. Kim, J. Huang, S. R. Michaelsen, I. J. Christensen, K. Grunnet, M.-T. Stockhausen, H. Broholm, M. Kosteljanetz, H. S. Poulsen, M. Tieu, E. Lovblom, M. Macnamara, W. Mason, D. Rodin, E. Tai, K. Ubhi, N. Laperriere, B.-A. Millar, C. Menard, B. Perkins, C. Chung, J. Clarke, A. Molinaro, J. Phillips, N. Butowski, S. Chang, A. Perry, J. Costello, A. DeSilva, J. Rabbitt, M. Prados, A. L. Cohen, C. Anker, D. Shrieve, B. Hall, K. Salzman, R. Jensen, H. Colman, O. Farber, U. Weinberg, Y. Palti, B. Fisher, H. Chen, D. Macdonald, G. Lesser, S. Coons, D. Brachman, S. Ryu, M. Werner-Wasik, J.-P. Bahary, A. Chakravarti, M. Mehta, T. Gupta, V. Nair, S. Epari, J. Godasastri, A. Moiyadi, P. Shetty, S. Juvekar, R. Jalali, U. Herrlinger, N. Schafer, J. Steinbach, A. Weyerbrock, P. Hau, R. Goldbrunner, R. Kohnen, H. Urbach, W. Stummer, M. Glas, C. Houillier, H. Ghesquieres, C. Chabrot, C. Soussain, G. Ahle, S. Choquet, P. Faurie, J.-O. Bay, J. Vargaftig, C. Gaultier, E. Nicolas-Virelizier, K. Hoang-Xuan, O. Iskanderani, F. Izar, A. Benouaich-Amiel, T. Filleron, E. Moyal, C. Iweha, S. Jain, E. Melian, A. Sethi, K. Albain, D. Shafer, B. Emami, X.-T. Kong, S. Green, E. Filka, R. Green, W. Yong, P. Nghiemphu, T. Cloughesy, A. Lai, S. Mallick, S. Roy, S. Purkait, S. Gupta, P. K. Julka, G. K. Rath, C. Marosi, J. Thaler, C. Ay, A. Kaider, E.-M. Reitter, J. Haselbock, M. Preusser, B. Flechl, C. Zielinski, I. Pabinger, S.-I. Miyatake, M. Furuse, T. Miyata, E. Yoritsune, S. Kawabata, T. Kuroiwa, Y. Muragaki, T. Maruyama, H. Iseki, J. Akimoto, S. Ikuta, M. Nitta, K. Maebayashi, T. Saito, Y. Okada, S. Kaneko, A. Matsumura, K. Karasawa, Y. Nakazato, T. Kayama, L. B. Nabors, K. L. Fink, T. Mikkelsen, D. Grujicic, R. Tarnawski, D.-H. Nam, M. Mazurkiewicz, M. Salacz, L. Ashby, L. Thurzo, V. Zagonel, R. Depenni, J. R. Perry, J. Henslee-Downey, M. Picard, D. A. Reardon, N. Nambudiri, L. Nayak, D. LaFrankie, P. Wen, D. Ney, J. Carlson, D. Damek, P. Blatchford, L. Gaspar, B. Kavanagh, A. Waziri, K. Lillehei, K. Reddy, C. Chen, I. Rashed, K. Barton, D. Anderson, V. Prabhu, R. Rusch, M. Belongia, M. Maheshwari, S. Firat, D. Schiff, A. Desjardins, M. Glantz, M. Chamberlain, W. Shapiro, S. Gopal, K. Judy, S. Patel, A. Mahapatra, J. Shan, D. Gupta, K. Shih, J. A. Bacha, D. Brown, W. J. Garner, A. Steino, R. Schwart, S. Kanekal, M. Li, L. Lopez, H. A. Burris, C. Soderberg-Naucler, A. Rahbar, G. Stragliotto, A. J. Song, A. M. S. Kumar, E. S. Murphy, T. Tekautz, J. H. Suh, V. Recinos, S. T. Chao, J. Spoor, K. Korami, J. Kloezeman, R. Balvers, C. Dirven, M. Lamfers, S. Leenstra, A. Sumrall, D. Haggstrom, A. Crimaldi, J. Symanowski, P. Giglio, A. Asher, S. Burri, G. Sunkersett, Z. Khatib, C. M. Prajapati, E. E. Magalona, M. Mariano, I. M. Sih, R. Torcuator, W. Taal, H. Oosterkamp, A. Walenkamp, L. Beerenpoot, M. Hanse, J. Buter, A. Honkoop, D. Boerman, F. de Vos, R. Jansen, F. van der Berkmortel, D. Brandsma, R. Enting, J. Kros, J. Bromberg, I. van Heuvel, M. Smits, R. van der Holt, R. Vernhout, M. van den Bent, W. Wick, C. Suarez, J. Rodon, P. Forsyth, I. Gueorguieva, A. Cleverly, T. Burkholder, D. Desaiah, M. Lahn, L. Zach, D. Guez, D. Last, D. Daniels, O. Nissim, Y. Grober, C. Hoffmann, D. Nass, A. Talianski, R. Spiegelmann, Z. Cohen, and Y. Mardor

Subjects
Abstracts, Cancer Research, medicine.medical_specialty, Text mining, Oncology, business.industry, Medicine, Medical physics, Neurology (clinical), business, Medical radiation
Published
2013

3. Efficacy and Feasibility of Intensity-Modulated Radiation Therapy for Prostate Cancer in Renal Transplant Recipients

Author

Hideki Ishida, T. Kondo, Tomokazu Shimizu, Toshio Takagi, Taiji Nozaki, Yai. Hashimoto, Yas. Hashimoto, Junpei Iizuka, Kenneth K. Tanabe, Tetsuo Akimoto, and K. Karasawa

Subjects
Oncology, Male, medicine.medical_specialty, Time Factors, medicine.medical_treatment, 030232 urology & nephrology, Urology, Renal function, Adenocarcinoma, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, Internal medicine, medicine, Humans, Kidney transplantation, Aged, Retrospective Studies, Transplantation, Genitourinary system, business.industry, Prostatic Neoplasms, Retrospective cohort study, medicine.disease, Kidney Transplantation, Radiation therapy, Treatment Outcome, 030220 oncology & carcinogenesis, Feasibility Studies, Kidney Failure, Chronic, Surgery, Hemodialysis, Radiotherapy, Intensity-Modulated, business
Abstract

Background In transplant patients with localized prostate cancer, irradiation is not proposed as often as it is in healthy adults because of the post-radiation risks, such as ureteral stenosis and gastrointestinal toxicity as the result of fragile tissue. The objective of the study was to analyze the efficacy and feasibility of intensity-modulated radiation therapy (IMRT) for prostate cancer in renal transplant recipients (RTRs). Methods Between May 2005 and December 2014, all patients who had undergone IMRT for clinically localized prostate cancer at our institution were retrospectively identified (n = 365). Of these patients, 2 had a history of renal transplantation. We reviewed all available clinical data. One patient had a functioning graft and the other had restarted hemodialysis 7 years after the transplantation. Results The mean time from renal transplantation to prostate cancer diagnosis was 11 years. The mean follow-up after irradiation was 43 months. The 2 patients remain free of prostate-specific antigen progression. There was no severe acute and chronic genitourinary and gastrointestinal toxicity. Renal function of the patient with a functioning graft as measured by serum creatinine was stable during and after the irradiation. Conclusions IMRT is feasible and acceptable as a minimally invasive treatment in the carefully selected RTRs with localized prostate cancer. This treatment should be considered a good option for RTRs with localized prostate cancer.

Published
2015

4. Efficacy and Feasibility of Low-Dose Rate Brachytherapy for Prostate Cancer in Renal Transplant Recipients

Author

Taiji Nozaki, Yai. Hashimoto, Toshio Takagi, K. Karasawa, Tetsuo Akimoto, Hideki Ishida, Junpei Iizuka, Tomokazu Shimizu, Yas. Hashimoto, Kenneth K. Tanabe, and T. Kondo

Subjects
Male, medicine.medical_specialty, medicine.medical_treatment, Brachytherapy, Population, 030232 urology & nephrology, Urology, Adenocarcinoma, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, medicine, Humans, education, Kidney transplantation, Aged, Retrospective Studies, Transplantation, education.field_of_study, Prostatectomy, business.industry, Prostatic Neoplasms, Middle Aged, medicine.disease, Kidney Transplantation, Low-Dose Rate Brachytherapy, Radiation therapy, Treatment Outcome, 030220 oncology & carcinogenesis, Feasibility Studies, Kidney Failure, Chronic, Surgery, business
Abstract

Background In young patients with localized prostate cancer, radical prostatectomy is the treatment of choice in the general population. Radiotherapy, such as low-dose rate (LDR) brachytherapy or intensity-modulated radiotherapy, is a viable alternative as well. However, in transplant patients, irradiation is not proposed as often as it is in healthy adults because of the risk of post-radiation ureteral stenosis and gastrointestinal toxicity as the result of fragile tissue. The objective of the study was to assess the efficacy and feasibility of LDR brachytherapy for prostate cancer in renal transplant recipients (RTRs). Methods Between May 2007 and December 2014, all patients who had undergone LDR brachytherapy for clinically localized prostate cancer at our institution were retrospectively identified (n = 203). Of these patients, 2 had a history of renal transplantation. We reviewed all available clinical data retrospectively. One patient had a functioning graft and the other had re-started hemodialysis 7 years after the transplantation. Results The mean time from renal transplantation to prostate cancer diagnosis was 16 years. The mean follow-up after seed implantation was 45 months. There were no peri-operative complications after seed implantation. The 2 patients remained free of prostate-specific antigen progression during the follow-up period. The renal function of the patient with a functioning graft, as measured by serum creatinine, was stable during and after the operation. Conclusions LDR brachytherapy is technically feasible and acceptable as a minimally invasive treatment in carefully selected RTRs with localized prostate cancer. This treatment should be considered a suitable option for RTRs with localized prostate cancer.

Published
2015

5. Long-term progression-free survival of invasive uterine cervical carcinoma infected with human immunodeficiency virus: a case report

Author

K. Karasawa, Yuzuru Niibe, and Katsumi Mizutani

Subjects
Pathology, medicine.medical_specialty, Time Factors, medicine.medical_treatment, Human immunodeficiency virus (HIV), Uterine Cervical Neoplasms, HIV Infections, medicine.disease_cause, Immune system, Acquired immunodeficiency syndrome (AIDS), Cervical carcinoma, Medicine, Humans, Neoplasm Invasiveness, Progression-free survival, Survival analysis, business.industry, Carcinoma, Obstetrics and Gynecology, Middle Aged, medicine.disease, Prognosis, Survival Analysis, CD4 Lymphocyte Count, Radiation therapy, Oncology, Cancer cell, Disease Progression, Female, business
Abstract

We report the case of a patient with invasive uterine cervical carcinoma, who is also infected with human immunodeficiency virus. This patient has had the longest progression-free survival of any with acquired immunodeficiency syndrome uterine cervical carcinoma. She was found to be human immunodeficiency virus positive in February 1996 and found to have uterine cervical carcinoma stage IB in July 1996. Shortly thereafter, she underwent radiation therapy. She died of renal and liver failure in January 1999. However, no residual tumor existed at that time. The longest progression-free survival in this case may be attributable to maintenance of the CD4 cell count from the onset of uterine cervical carcinoma to death, which meant the patient's immune system to the cancer cells worked.

Published
2005

6. Preparation of lipid-derivatized glycosaminoglycans to probe a regulatory function of the carbohydrate moieties of proteoglycans in cell-matrix interaction

Author

K Karasawa, Koji Kimata, S Suzuki, Y. Hori, Nobuo Sugiura, and K. Sakurai

Subjects
biology, Chemistry, Cell Biology, Heparin, Adhesion, Heparan sulfate, Biochemistry, Extracellular matrix, Fibronectin, Glycosaminoglycan, chemistry.chemical_compound, Proteoglycan, medicine, biology.protein, Chondroitin sulfate, Molecular Biology, medicine.drug
Abstract

We have shown previously that chondroitin sulfate, but not heparan sulfate/heparin, linked to either natural core proteins or serum albumin interferes with cell-to-substrate adhesion, provided that the external proteoglycans are topologically immobilized on plastic plates. In order to study the roles of glycosaminoglycan chains (GAGs) as recognition structure, a new assay system is now developed which involves the conversion of free GAGs to reactive lactone derivatives selectively modified at the reducing end. The modified GAGs can be coupled to the amino group of phosphatidylethanolamino (PE) for use as probes on either plastic plates or cell surfaces. Incubation of GAG-PE solutions in polystyrene plates results in a time- and dose-dependent increase of the density of the GAG chains noncovalently immobilized onto the plates. No immobilization is detected with any of the GAG-PE samples that have been treated with phospholipase D. A M(r) 30,000 chondroitin sulfate conjugate to PE (CS-PE), when immobilized onto a fibronectin-coated well for 2 h at an initial concentration of 0.06 microgram/100 microliters/well, inhibits the adhesion of baby hamster kidney (BHK) cells to the substratum by approximately 50%, whereas heparin-, heparan sulfate-, hyaluronic acid-, and dermatan sulfate-PE do not. The effect of CS-PE is abolished by treating the CS-PE-coated plates with chondroitinase ABC. A similar level of inhibition by CS-PE is found when the RGD-containing 120-kDa fragment of fibronectin is used in place of fibronectin. CS-PE in soluble form, once exposed to BHK cells in suspension, can be associated with the cell surfaces, thereby exerting some inhibitory effects on cell-to-substrate adhesion. On a per mol basis, however, the activity of cell-associated CS-PE is far lower than that of substrate-associated CS-PE. Together the results indicate that our GAG-PEs offer useful tools for probing regulatory function of the GAG moieties of proteoglycans and further support the hypothesis that the inhibitory regulation of cell-to-matrix adhesion by large chondroitin sulfate proteoglycans is caused by an interaction between the cell surface and the chondroitin sulfate chains topologically immobilized on extracellular matrices.

Published
1993

7. Molecular remission in adult T cell leukemia after autologous CD34+ peripheral blood stem cell transplantation

Author

S Tanikawa, T Inoue, Kiyoshi Hiruma, T Sasaki, Kazuteru Ohashi, S Mori, Hisashi Sakamaki, Yoshiki Okuyama, A Moriya, H Akiyama, Yasuhiro Maeda, Y Sato, K Karasawa, and M Nakane

Subjects
Leukemia, T-Cell, Cyclophosphamide, T-cell leukemia, Antigens, CD34, Polymerase Chain Reaction, Transplantation, Autologous, hemic and lymphatic diseases, Acute lymphocytic leukemia, medicine, Humans, Transplantation, business.industry, Remission Induction, Hematopoietic Stem Cell Transplantation, Hematology, Total body irradiation, Middle Aged, medicine.disease, Minimal residual disease, Immunology, Cytarabine, Cancer research, Neoplastic Stem Cells, Female, Stem cell, business, medicine.drug
Abstract

This report describes a patient with acute-type adult T cell leukemia/lymphoma (ATLL) successfully treated by autologous CD34+ peripheral blood stem cell transplantation after fractionated total body irradiation and high-dose cytarabine and cyclophosphamide. A newly established inverse polymerase chain reaction method was used to demonstrate the disappearance of ATLL clonal cells. The patient achieved a sustained molecular remission after transplantation, but died from opportunistic infection 4 months after transplantation. Thus, autologous CD34+ peripheral blood stem cell transplantation is promising for this type of malignancy. However, a prudent clinical attitude toward immunological fragility after transplantation is needed for better outcome.

Published
1999

8. SRPX2 is a Novel Chondroitin Sulfate Proteoglycan that is Overexpressed in Gastrointestinal Cancer

Author

T. Hirashima, Y. Omuro, C. Kondo, T. Kanematsu, K. Muraki, Po-Chuan Wang, K. Ishiguro, Young-Ae Park, C.-Y. Lu, C.-C. Liao, H. Tei, H. Takeyama, M. Toishi, A. D. Abdullah, M. Terada, K. Yamamoto, N. Yamamoto, K. Fujii, M. Sugimoto, H. Kakizaki, K. Shinozaki, Y. Okada, Yoko Inaguma, S. Shimizu, Shigeki Ito, H. Y. Lim, N. Nogami, N. Awata, M. Nishioka, H. Ueoka, Tomoya Ishii, Y. Ahn, Kazumichi Kawakubo, Y. Aoyagi, C. Nishijima, R. Kameda, A. Okamoto, Y. Yamashita-Kashima, H. Suzuki, K. Yamao, A. Yonemori, H. Fukuda, H. Katayama, K. Honoki, T. Nomura, Y. Tono, T. Shimoyama, J. Nagano, H. Miyamoto, Y. Takeda, M. Fukutake, N. Katsumata, S. Fujita, K. Fujimoto-Ouchi, D. Tamura, H. Obaishi, S. Mitsunaga, J.-H. Baek, Yuichiro Tada, K. Uno, S. Oura, M. Nakamura, Y. Imanura, Atsushi Kumanogoh, M. Manabe, Kaoru Tanaka, T. Yokota, K. Saito, K. Tamura, Yukihiko Fujii, T. Lim, Toshihiko Tomita, C. Seki, Masafumi Taniwaki, Tomohide Sugiyama, N. Kunami, T. Yoshino, Y. Takeoka, T. Yoshikawa, Won-Suk Lee, M. Hattori, H. Yasui, T. Motoya, T. Nishizaki, N. Kouge, E. Sato, S.H. Park, J.H. Hong, N. Mori, M. Tajika, K. Yasuda, Mika Nakamae, Kazuya Fukuoka, T. Shimomura, A. Suzuki, M. Arima, Hideo Koh, S. Tokunaga, N. Miyamoto, Masao Nakata, T. Ueda, Hideharu Kimura, H. Nakano, Kimikazu Yakushijin, M. Hayashi, K. Ishitani, K. Yoshida, T. Takeuchi, Shohei Yokota, K. Hirano, N. Horikawa, S. Bandoh, G. Naka, Y. Seki, M. A. De Velasco, F. Tanikawa, S. Hirano, S. Ohkawa, S. Kadowaki, M. Sakurai, R. Kaji, J.-I. Lee, K. Kitahara, K. Nihei, T. Sumi, Meiki Fukuda, S. Park, K. Nosaka, T. Maeda, O. Morimura, G. Sano, H.-L. Wu, Haruhiko Hirata, Mizuki Aimoto, Y. Igeta, K. Itoh, Y. Ikari, Kentaro Iwanaga, K. Itatsu, Akira Ueda, C. Oabata, H. Fujiwara, T. W. Kim, K. Misu, H. Mikayama, K. Morise, K. Nagata, M. Sato, Takashi Kijima, Kazuo Kasahara, Takahiro Mori, N. Mizuno, Y. Fujitani, Abdul Aziz Baba, K. Takashima, Kazuhide Higuchi, J.-C. Jo, G. Tamaki, S. Magoshi, R. Watanabe, A. Abe, M. Iino, H. Goto, Junji Tsurutani, Y. Katashiba, K. Kato, K. Hosono, L. Y. Kwan, Y. Okabe, N. Takeuchi, Chih-Hsin Tang, I. Kawase, Takayuki Kii, D. Kishino, K. Matsuura, K. Isobe, K. Monden, H. Udagawa, K. Kim, M. Tada, Kazuyoshi Yanagihara, Cheryn Song, T. Terui, Yasuhito Fujisaka, I. Yamaguchi, Hirokazu Fukui, K. Naito, T. Suzumura, H. A. Jung, N. Ureshino, Wataru Okamoto, H. Miyawaki, N. Nakamura, T. Tsukazaki, K. Furuta, K. Matsuda, S. J. Lee, Y. Ishiura, J.-L. Lee, Y. Kato, Shinichiro Hayashi, Y. Horita, J. H. Kim, Y. Tsutsumi, M. Inaoki, K.-P. Kim, Y. Ishigatsubo, T. Mikawa, M. Yamane, A. Husin, Yasufumi Takeshita, S. Kobayashi, N. Kubo, N. Hosono, Yeong-Shiau Pu, M. Ando, Keita Kudo, Hitoshi Nishitani, M. Mori, H. Daga, T. Fukuda, A. Nakaya, N. Fuse, I. Miki, W. Yamamoto, M. Fukushima, T. Ikezoe, H. Ueno, J.-H. Ahn, T. Matsumoto, A. Kuwahara, T. Ogura, N. Hirai, S. Mizuta, A. Ochiai, N. Masumori, S. Kim, Y. Ohki, Yoshinori Imamura, T. Tamaki, K. Nishino, Y. Aoyama, T. Ogawa, T. Koyama, M. Morise, K. Kawada, T. Masaki, Keishi Yamashita, S. Yamamoto, K. Tanimoto, M. Hori, Atsuo Okamura, Masataka Ikeda, K. Oishi, H. Hashimoto, Y. Ohe, M. Yasui, Y. Akatsuka, F. Imamura, Y. Hirayama, Ho Young Kim, S. Kishi, M. Jung, Y. Inukai, K. Miwa, S.-H. Nam, T. Hishima, T. Okusaka, Y. Horiuchi, A. Ioka, W. Fukushima, M. Yamauchi, N. Hokamura, K. Hirata, Y. Katou, K. Tada, K. Suzuki, K. Teramoto, Syusai Yamada, M. Iikura, Takeo Shimasaki, Y. Inoue, K. Kawahara, T. Kitani, H. Sawai, T. Terashima, K. Honda, Hitomi Umeguchi, Masataka Okamoto, M. Kita, Y. Yatabe, Y.-M. Cho, Sojiro Kusumoto, K. Hokkoku, Takaaki Sasaki, Masayuki Hino, M. Omi, H. Tanaka, S. Kawazoe, M. Sakai, H. Tsuchihashi, Kazushi Endo, R. Mauchi, K. Ohashi, H. Takasaki, N. Naganobu, K. Aoe, S.Y. Oh, C. Honma, Takahiro Miyamoto, K. Yamazaki, M. Fujii, T. Fujisawa, S. Morikawa, T. Yamauchi, Masayoshi Kobune, K. Kuwano, T. Onikubo, M. Kuyama, M. Asayama, T. Kozuki, M. Kanie, Masahiko Shibuya, Y. Yamamoto, N. Morishita, Y. Yoshii, Toru Mukohara, K. Izumi, Y.S. Park, N.-R. Lee, Y. Horio, K. Nakamura, M. Matsuda, K. Sugino, S.H. Lee, S. Ueno, Tsutomu Sato, Y. Hasumi, H. Yamamoto, T. Karasuno, Yong Chan Ahn, M. Kitamura, Y. Namba, K. Karasawa, S. Hayasi, K. Hashimoto, Y. Ozaki, Takayuki Takahama, A. Todaka, M. Inoue, S. Boku, A. Ohtsu, Tadashi Matsunaga, K. Togitani, H.-H. Wu, Hirofumi Kogure, H. Kitamura, T. Matsuzaki, M. Gouchi, Hyun-Jin Kim, T. Shiroyama, K. Okada, Y. Terasaki, K. Park, H. Katou, N. Kobayashi, D. Mohri, Y. Hasegawa, T. Yoshimasu, Masahiro Tabata, S. Hijioka, Y.-Y. Chen, Shinji Nakao, M. Kodaira, Akihiko Gemma, T. Yoshida, Hiroya Takiuchi, Masaki Fujimura, A. Shimoda, Hiroyuki Isayama, K. Ohta, T.-L. Chen, T. Maruyama, K. Maruyama, K.-W. Lee, Takashi Hirose, Y. Fujita, H. Kato, Maya Watanabe, S. Iwasa, H. Okuyama, Cherry Wu, A. Hata, K. Myo, M. Takase, Y. Urasaki, K. Shingu, Shingo Nishikawa, M. Tsuzuki, I. Hoshi, T. Maruo, Hiroki Yoshita, Hirohisa Nakamae, Shigeru Hatabe, Hideko Ikeda, Hayato Koba, Y. Hata, S. Matsushima, M. Yunokawa, S. Tamaru, J. S. Ahn, T. Funakoshi, S.-J. Jang, S. Kageyama, K. Nakagawa, H. Nishimori, Eizaburo Sueoka, K. Hashidume, S. H. Hong, Atsushi Kawaguchi, Tomomi Nakamura, H. Kaneko, A. Seki, K.-L. Tan, T. Ichimura, Y. Matsuda, M. Nezu, M. Kudo, H. Fujii, K. Shibata, S. J. Sym, K. Takeuchi, Chiharu Tabata, M. Takeshita, Y. Ueda, A. Nakayama, N. Nishiyama, Sang We Kim, Y. S. Kim, H. Suzushima, S. Soma, K. Miura, H. Gonda, D. Gomi, A. Mogi, K. Ishizuka, T. Mizutani, Y. Yamada, A. Sato, G. Kaneko, T. Samejima, R. Shimabukuro, Masahide Fujita, K. Horie, R. Ohhashi, T. Wakasa, H. Nomura, K. Sato, T. Hamaguchi, S. Horiguchi, M. Ootsuka, S. Kawabata, Y. Okamoto, A. Yoshida, H. Takeda, M. Sugiyama, Y. S. Hong, Y. Yanagita, Yasushi Ichikawa, K. Tomii, T. Enokida, Tzyh-Chyuan Hour, Y. Takeyama, Y. Matsuura, Y. Kakehi, S. Kanazawa, S. Kimura, T. Yamada-Murano, D. Abe, Nagio Takigawa, T. Yana, A. Ogino, R. Sakai, S. Watanabe, K. A. Kwon, Y. Nakai, O. Watanabe, Naokatsu Nakada, Masanori Toyoda, H. Inomata, R. Sekine, J. S. Lee, T. Shukuya, O. Ishiko, Y. Ikeda, K. Nakase, S. Kuzu, H. Mukai, K. Ozaki, R. Koyama, Takashi Nakano, K. Hashizume, E. Noguchi, N. Hida, Y. Takamatsu, Tomoko Yamagishi, H. Agatsuma, S. Miyamoto, D.H. Lee, H. Kunimoto, H. Ogino, T. Miya, Naoki Sasahira, A. Yamane, T. Takami, N. Imai, Y. Fukui, Tae Min Kim, T. Kita, Jiro Watari, H. Kawabata, N. Motohashi, K. Aomatsu, T. Obayashi, H. Hayashi, S.-H. Li, S. Sakata, H. Okada, K. Masa, T. Iwata, H. Yoshida, Tokuzo Arao, R. Hassan, H. Imaoka, M. Kobayashi, H. Iwasaki, K. Nomura, H. Harada, T. Watanabe, K. Kaneko, H. Nakagawa, K. Sakamoto, A. Hiasa, Katsuyuki Hotta, Nobuhiko Emi, S. Maruyama, M. Yonemura, H. Tsurumi, Takuhiro Yamaguchi, M. Nagata, T. Nakai, Motoki Yoshida, S. Motomura, A. Sakai, H. Inoue, Toshimitsu Yamaoka, T. Morikita, S. Hirokawa, Hideaki Ijichi, Namiki Masayuki, Meiko Nishimura, Y. Ishii, A. Shimatani, Jong-Hyeok Kim, M. Ujihara, Yuko Kanbayashi, Y. Nakashima, T. Hosoda, K. Sanada, S. Kondo, Y. Honma, S. Sakamoto, H. Kubo, M. Kondo, F. Nomura, M. Hashizume, T. Shiraishi, B.-S. Kim, T. Kouno, T. Maki, H. Akaike, Z. Saito, Junya Fukuoka, T. Ohnishi, C. H. Maeng, M. Wada, Jong-Mu Sun, C. Morizane, Y. Matsumoto, K. Migita, Y. Okamura, Sun Young Rha, Hiroyoshi Ichihara, J. Kato, N. Yoshimura, W.-J. Wu, N. Wada, M. Yoshihara, K. Hamai, Kazuhiko Koike, Woo Kyun Bae, Y. Maeda, S. Mimura, Y. Sakai, H. Wakasugi, H. Nishimoto, M. Nagano, K. Taira, I. Park, T. Inokuma, Katsuhiko Shimizu, Y. Nakahara, S. Okamura, K. Ogawa, F. Saito, Y. Miura, Hyo Jin Lee, K. Fujita, K. Takagi, T. Shiina, Charny Park, Shin Kuwakado, N. Moto, Y.-C. Chiu, S. Saji, T. Araya, J. Takeshita, H. Iwase, Naoe Goto, H. Murakami, T. Hayashi, K. Otsuka, Rishu Takimoto, H. Nakahama, C.-C. Shih, Naoko Aragane, S. Hamauchi, H. K. Ahn, N. Tomita, N. Chyayahara, T. Hida, K. Watanabe, Y. Kokubo, N. Katusmata, L. K. Chi, M. Okumura, T. Kusakabe, S. Homma, H. Nakagomi, Hiroo Katsuya, D. B. Shin, Naoko Chayahara, F. Fukuta, Kazutoshi Shibuya, Ayumu Hosokawa, F. Ota, R. Yoshino, M. Goto, Y. Shibata, J. E. Kim, H. Watanabe, K. Mandai, T. Shimamura, S. Inoue, M. Fujimoto, S. Mitsuoka, Kunio Okamoto, M.-J. Kim, E. Chung, H. Moriwaki, Y. Misumi, S. Ogawa, K. C. Lee, J.-O. Lee, H. Hirosawa, Yoshiki Terada, A. Kinoshita, J. Hong, Y. J. Kim, A. Kido, M. Kijima, Y. Shiota, H. Hayase, A. Sekikawa, M. Ahn, K. Komuta, M. Sasaki, T. Murakami, M. Okuda, N. Matsubara, R. Saitou, R. Nakamura, K. Masuo, Kazuko Matsumoto, K. Mouri, Y. Ookuma, Kazutoshi Komiya, K. Sakai, N. Yogo, Takahiko Nakane, M. Mukai, Isao Tachibana, Shiro Kimbara, Kentaro Okuda, T. Fujisaki, S.-J. Chuang, Y. Niwa, H. Oda, Y. Nishida, T. Ando, Yuichi Ando, J. Tong, C. Shimizu, J. Choi, Satoshi Iyama, H. Imai, K. H. Park, T. Misao, Yohei Funakoshi, Chang-Sik Yu, Tadashi Kimura, J. Hori, M. Itoh, S. Ebihara, S.-H. Gan, T. Yano, H. Okamoto, E. Fukutani, U. Tateishi, T. Ishihara, Takuro Yoshimura, T. Shinkai, A. Yokoyama, T. Kikuchi, Y. Yamashita, K. Hagiwara, Y. Noda, Y. Oyama, K. Okuno, Naomi Kiyota, K. Yonemori, K. Kuramoto, T. Shimoi, H. Hong, Ryuya Yamanaka, E. Matsuki, O. Kondo, H. Gondou, Yusuke Nakamura, M.-J. Ahn, Yoshiki Hayashi, Shiro Koh, S. Kosaka, Masahiro Gotoh, S. Mizuno, H. Nakamura, S. Okazaki, E. Ichiki, M. Ishizu, K. Ishikawa, Hiroyasu Kaneda, R. Yamamura, Tomonobu Koizumi, R. Ankathil, T. Takahashi, S. Nakatsuka, A. Kamuro, M. Ueno, T. Eguchi, S. Hirai, G. Saito, S. Kudoh, Masanao Nakashima, N. Okamoto, K. Akiyoshi, Hironobu Minami, K. Kubota, K. Okafuji, M. Aoe, T. Ito, K. Nishimura, S. Ota, C. Wong, A. Ooki, Takao Shirai, Wen-Yi Chou, M. Tamiya, H. Tabuse, Y. Kaneko, Y. Shimizu, Y. Murata, A. Okada, S. Sasada, Y. Takagi, A. Naitou, N. Katayama, Kaori Ito, T. Araki, Y. Fujiwara, H. Yokota, Shinya Kajiura, M. Imano, T. Iwai, T. Kobayashi, T. Kubota, N. Kanaji, M. Ohdate, T. Tsukamoto, S. Zenda, A. Fukutomi, T. Kumura, R. Ogawa, K. Shintaku, Kazuto Nishio, T. Morimoto, W. Shioyama, E. K. Cho, H.-I. Lu, Y. Suginoshita, K. Yamaguchi, Y. Shindo, N. Hirokami, J. Shimizu, Chihiro Makimura, K. Araki, T. Taniyama, T. Tanaka, Y. Tanbo, Hiroto Miwa, Y. Hirai, J. Park, Asao Hirose, M. Doi, A. Goto, S. Nomura, S. Ikegaya, A. Yoshii, M. Akahane, T. Kakuma, K. Miyabayashi, S. Y. Kim, H. Kitade, B. Han, K. Yamada, Tadayuki Oshima, J. Ishizawa, M. Miyata, E. Sasak, R. Aibara, N. Takahara, S. Kanno, T. Kojima, I. Ohno, E. Sasaki, E. Tone, A. Morita, R. Suzuki, Yukio Hosomi, Hiroo Ishida, T. Akimoto, N. Hashimoto, T. Takakuwa, K. Umekawa, A. Toyoshima, K. Hara, J. Kitagawa, H. Taniguchi, T. Kamiya, M. Takai, Y. Watanabe, Yasuhito Tanaka, A. Sawada, T. Yasui, Y. Onozawa, Akihiro Hirakawa, S. Okamoto, K. K. Kim, Y.-M. Wang, Y. Takai, T. Tsumura, H. Hirama, Shigeo Horiike, K. Kawasumi, N. Shimeno, Junya Kuroda, C.-Y. Huang, Y.-H. Chen, H. Ogata, S. Matsumoto, I. Takahashi, Hideo Tomioka, I. Okamoto, Itaru Endo, T. M. S. Kam, K. Sekihara, C.-T. Liu, K. Chikamori, N. Hirota, K. Hiramatsu, D. Hamaguchi, T. Nishii, N. Ohmiya, T. Shimizu, T. Sakaizawa, Hiromichi Matsuoka, K. Kawa, J. H. Ji, S. Izumi, T. Hara, Y. Tsuyumu, T. Oguri, T. Akiyama, Y. Ichida, A. Simoyama, T. Hirakata, Y. Yoshimitsu, Y. Sasaki, T. Yamazaki, T. Tsushima, R. Okamoto, Y. Tsukioka, Nobuhiko Seki, S.-M. Bang, Y. Kubota, N. Harada, C.-H. Huang, J. Y. Hong, T. Andou, T. Shimada, T. Doi, Yoshihiro Ono, S. Nanjo, H. Hara, Y. Kikukawa, M. K. Choi, K.-M. Rau, Y. Tomizawa, O. Maeda, K. Ishida, Y. Naito, N. Machida, T. Otsuka, T. Hase, H. Morishita, K. Fukuhara, M. Yoshino, M. Takahashi, H. Takahashi, Heui June Ahn, M. Nisimoto, Y. Sunakawa, Y. Miyakawa, Choung Soo Kim, S.-W. Wang, Takashi Sone, M. Iguchi, T. Shimokawa, Tomoyuki Nagai, K. Morioka, A. Numata, R. Toyozawa, R. Miyahara, Y. M. Ahn, Hyo Song Kim, D. W. Hwang, H. Takamori, Shin-Hee Lee, Narikazu Boku, T. Mizuno, N. Katakami, J. H. Lee, Y. Okuma, Koji Kurokawa, K. Takeda, N. Sakiyama, R. Tachikawa, Satoshi Morita, T. K. Fai, K. H. Seong, K. Yorozu, T. Okamura, Ryo Takahashi, T. Kotake, Y. Arai, T. Kawamura, K. Yakushijinn, Y. Shimada, H. Sugiyama, S. Kamachi, A. Mugitani, T. Yasue, Y. Sugihara, S. Shu, Y. Osaki, Kazuhisa Takahashi, Y. Hashiguchi, K. Funasaka, Y. S. Koo, Tohru Ohmori, S. J. Koh, N. Kanemura, H. Kotani, M. Hsin, T. Kagoo, and A. Inoue

Subjects
biology, Molecular mass, business.industry, Angiogenesis, Hematology, Cell biology, chemistry.chemical_compound, Oncology, chemistry, Proteoglycan, Chondroitin sulfate proteoglycan, Cancer cell, medicine, biology.protein, Hepatocyte growth factor, Antibody, Cell adhesion, business, medicine.drug
Abstract

SRPX2 (Sushi repeat-containing protein, X-linked 2) has recently emerged as a multifunctional protein that is involved in seizure disorders, angiogenesis and cellular adhesion. Here, we analyzed this protein biochemically. SRPX2 protein was secreted with a highly post-translational modification. Chondroitinase ABC treatment completely decreased the molecular mass of purified SRPX2 protein to its predicted size, whereas heparitinase, keratanase and hyaluroinidase did not. Secreted SRPX2 protein was also detected using an anti-chondroitin sulfate antibody. These results indicate that SRPX2 is a novel chondroitin sulfate proteoglycan (CSPG). Furthermore, a binding assay revealed that hepatocyte growth factor dose-dependently binds to SRPX2 protein, and a ligand–glycosaminoglycans interaction was speculated to be likely in proteoglycans. Regarding its molecular architecture, SRPX2 has sushi repeat modules similar to four other CSPGs/lecticans; however, the molecular architecture of SRPX2 seems to be quite different from that of the lecticans. Taken together, we found that SRPX2 is a novel CSPG that is overexpressed in gastrointestinal cancer cells. Our findings provide key glycobiological insight into SRPX2 in cancer cells and demonstrate that SRPX2 is a new member of the cancer-related proteoglycan family.

Published
2012

9. SU-E-T-214: Volumetric Particle Beam Quality Assurance

Author

K Karasawa, S Utsunomiya, and Eric E. Klein

Subjects
Range (particle radiation), Materials science, Particle therapy, Proton, business.industry, System of measurement, medicine.medical_treatment, General Medicine, Electron, Imaging phantom, Optics, medicine, business, Nuclear medicine, Particle beam, Quality assurance
Abstract

Purpose: Quality assurance (QA) and dose output measurements for particle therapy, where the range varies across the field is a challenge. Our goal was to devise a system that was both accurate and efficient. Methods: We have utilized a MatriXX(IBA) device in a protective sleeve within water to measure absolute dose and profiles. The MatriXXcan be positioned remotely to various depths in water. For high energy electrons (using a custom compensator‐CC) and protons (range compensator) depths may be chosen according to the therapeutic ranges across the field. Measured data was compared to phantom calculated profiles using the I'mRTsoftware (IBA). Two CC were constructed, CT scanned, and calculated, on top of a test phantom. The CC in front of a water phantom was irradiated with 20 MeV electrons. One CC was intentionally altered (added plastic narrow ring) to ensure a deviation could be detected. Setup and measurement times were recorded. Results: We found good agreement between measured absolute dose/profiles and calculations for two CCs at three depths (6.17, 8.17 and 10.17 cm). The Gamma index (3 mm, 3%) was calculated to be met over the majority of irradiated field. The MatriXX accurately detected the intentionally altered CC by for the measurement vs. the calculated plan. Setup and measurement times were reasonable for routine patient specific QA (∼5 min. per CC tested) excluding setup. Conclusions: The results indicate our measurement system using the MatriXX device in water was sufficient for measuring dose and profiles for electrons. We plan on performing dose output and profile measurements for proton patients when we go clinical in 2012. We anticipate performing QA for as many as 6 proton fields in

Published
2011

10. Concurrent Chemoradiotherapy for Unresectable Locally Advanced Pancreatic Adenocarcinoma: Impact of Adjuvant Chemotherapy on Local Control and Survival

Author

Y. Ito, K. Ogawa, K. Shibuya, S. Nishino, H. Shibuya, K. Karasawa, T. Kazumoto, K. Nemoto, and Y. Nishimura

Subjects
Oncology, Cancer Research, medicine.medical_specialty, Radiation, Adjuvant chemotherapy, business.industry, Locally advanced, medicine.disease, Concurrent chemoradiotherapy, Internal medicine, medicine, Adenocarcinoma, Radiology, Nuclear Medicine and imaging, business
Published
2010

11. P-722 Stereotactic radiosurgery for patients with brain metastases fromlung cancer

Author

M. Suzuki, K. Karasawa, T. Takada, Y. Fukuchi, Y. Hirokawa, K. Ito, and K. Takahashi

Subjects
Pulmonary and Respiratory Medicine, Cancer Research, medicine.medical_specialty, Oncology, business.industry, medicine.medical_treatment, medicine, Cancer, Radiology, business, medicine.disease, Radiosurgery
Published
2005

12. Weekly docetaxel (D) versus daily low dose cisplatin (P)/ fluorouracil (F) as neoadjuvant chemoradiotherapy (CRT) in patients with advanced esophageal cancer: Nonrandomized phase II results of a single institute

Author

H. Hirokawa, Masahiko Tsurumaru, Takayuki Amano, Fuyumi Isayama, Yoshimi Iwanuma, M. Okumura, K. Karasawa, Yoshiaki Kajiyama, and N. Tomita

Subjects
Oncology, Cisplatin, Cancer Research, medicine.medical_specialty, genetic structures, business.industry, Head and neck cancer, Urology, medicine.disease, Regimen, Dissection, Docetaxel, Fluorouracil, Internal medicine, medicine, Adverse effect, business, Chemoradiotherapy, medicine.drug
Abstract

4259 Background: (D) is now introduced as an agent for chemoradiotherapy in patients with head and neck cancer. We began to use (D) consecutively in patients with advanced esophageal cancer from January 2004 as an agent for neoadjuvant CRT, when the tumor was suspicious for invading to adjacent organs. We compared both pathologic effects and adverse events between (D) and (P) + (F) CRT as a neoadjuvant treatment. Methods: The neoadjuvant regimen was 40Gys of radiation with weekly (D: 10mg/m2) or daily (P: 10mg/body) + (F: 500mg/body). During CRT, adverse events were recorded according to NCI-CTC (ver.2.0). A month following CRT, transthoracic esophagectomy with lymph nodes dissection was performed, and pathologic effects of neoadjuvant CRT were judged. We consider a case as a pathologic responder when viable cancer cells account for less than 1/3 of tumor tissue microscopically. Results: 11 pts received (D) CRT, and 28 pts received (P) + (F) CRT. Pathologic response rate was 73% in (D), and 66% in (P) + (...

Published
2005

13. Japanese survey of treatment outcome of breast-conserving therapy in patients with positive or close surgical margins

Author

K. Karasawa, M. Mitsumori, C. Yamauchi, K. Gomi, M. Kataoka, T. Uematsu, T. Kodaira, M. Yamakawa, T. Watanabe, and K. Tujino

Subjects
Menopause pre, Cancer Research, medicine.medical_specialty, Radiation, Histological type, business.industry, Treatment outcome, Distant metastasis, Oncology, Internal medicine, medicine, Adjuvant therapy, Physical therapy, Radiology, Nuclear Medicine and imaging, Tumor bed, In patient, Whole breast, business
Abstract

Factors of analysis: Patients,tumor factor:Age, Menoposal status, t, n, ER, PgR, Histological type, DS, ly, v, NG, HG Treatment factor :Marginal status(positive,less than 2mm,2.1-5mm), Sugery, Dose of whole breast, Dose of tumor bed, Adjuvant therapy Follow up :Period,Local recurrence(site, period), Distant metastasis, Prognosis Registered Patients: All 1007 Eligible 941 (ineligible;T3、Follow up less than 2 years 66) Follow up period 2-14.1year (median4.9years) Age 24-83y.o. (median48y.o.) Menopause Pre 514 (55%) Term 108 (11%) Post 319 (34%)

Published
2004

16. Adenosquamous carcinoma of the lung: Clinical characteristics and prognosis

Author

M. Suyama, K. Kunishima, Yutaka Ariyoshi, M. Kuwahara, and K. Karasawa

Subjects
Pulmonary and Respiratory Medicine, Oncology, Cancer Research, medicine.medical_specialty, Lung, medicine.anatomical_structure, business.industry, Adenosquamous carcinoma, Internal medicine, Medicine, business, medicine.disease
Published
1991

18. Effect of beta-D-xyloside and cycloheximide on the synthesis of two types of proteochondroitin sulfate in chick embryo cartilage

Author

Y Kato, K Kimata, S Suzuki, K Ito, and K Karasawa

Subjects
chemistry.chemical_classification, Cartilage, Glycoside, Embryo, Cell Biology, Anatomy, Cycloheximide, Xylose, Biochemistry, chemistry.chemical_compound, medicine.anatomical_structure, chemistry, Chondroitin Sulfate Proteoglycans, medicine, Molecular Biology, Beta-D-xyloside, Proteochondroitin Sulfate
Published
1978

20. Serum creatine kinase in primary hypothermia

Author

K Karasawa, K Miyagi, H Dun, and S Shoji

Subjects
medicine.medical_specialty, Endocrinology, Primary (chemistry), business.industry, Internal medicine, Biochemistry (medical), Clinical Biochemistry, medicine, Serum creatine kinase, Hypothermia, medicine.symptom, business
Published
1989

21. Cornell Medical Index Applied to Health Control

Author

K. Karasawa, O. Kawasaki, and T. Mori

Subjects
Index (economics), business.industry, Control (management), Statistics, Public Health, Environmental and Occupational Health, Medicine, Toxicology, business
Published
1960

22. Immunocytochemical Investigation of Carbon Tetrachloride Induced Cirrhosis of the Liver in Rats

Author

K. Ogoshi, Y. Fujinaka, S. Tashiro, A. Kimura, K. Fukuchi, Tsutomu Sasagawa, K. Karasawa, and Y. Kinoshita

Subjects
medicine.medical_specialty, Cirrhosis, business.industry, Gastroenterology, Hepatology, medicine.disease, Colorectal surgery, chemistry.chemical_compound, chemistry, Surgical oncology, Internal medicine, medicine, Carbon tetrachloride, business, Abdominal surgery
Published
1967

23. Studies on the universal peritoneoscope: Especially the observation of the liver

Author

N. Kamijo, S. Oka, T. Tpmono, K. Karasawa, Y. Hagiwara, Masayuki Oda, M. Sugiura, T. Takahashi, K. Takei, and H. Takayama

Subjects
medicine.medical_specialty, Diagnostic information, business.industry, Gastroenterology, Hepatology, medicine.disease, Inflammatory cell infiltration, Colorectal surgery, Liver disease, Surgical oncology, Internal medicine, Medicine, business, Liver cancer, Abdominal surgery
Published
1972

24. Immunocytochemical study in hepatitis and hepatic cirrhosis (I)

Author

Y. Kinoshita, Y. Fujinaka, K. Karasawa, S. Tashiro, K. Fukuchi, Tsutomu Sasagawa, and S. Fujisaki

Subjects
Hepatitis, medicine.medical_specialty, Cirrhosis, business.industry, Gastroenterology, Hepatology, medicine.disease, Colorectal surgery, Surgical oncology, Internal medicine, medicine, business, Abdominal surgery
Published
1966

25. Studies on the effect of prednisolone on activity of transaminase in the liver, kidney and serum (III)

Author

T. Morita, S. Tashiro, Y. Kinoshita, K. Karasawa, K. Fukuchi, Tsutomu Sasagawa, and S. Fujisaki

Subjects
medicine.medical_specialty, Kidney, business.industry, Gastroenterology, Hepatology, Colorectal surgery, Transaminase, medicine.anatomical_structure, Biochemistry, Surgical oncology, Internal medicine, medicine, Prednisolone, business, medicine.drug, Abdominal surgery
Published
1966

26. Structure and disaccharidase activities in small intestine

Author

K. Ogoshi, A. Kimura, S. Tashiro, K. Karasawa, Y. Fujinaka, Tsutomu Sasagawa, and Y. Kinoshita

Subjects
medicine.medical_specialty, business.industry, Gastroenterology, Hepatology, Colorectal surgery, Small intestine, Disaccharidase, medicine.anatomical_structure, Surgical oncology, Internal medicine, medicine, business, Abdominal surgery
Published
1968

27. Primary nonspecific chronic ulceration of small intestine report of two cases in sisters

Author

Y. Kinoshita, A. Kimura, K. Karasawa, Y. Fujinaka, K. Ogoshi, S. Tashiro, and Tsutomu Sasagawa

Subjects
medicine.medical_specialty, medicine.anatomical_structure, business.industry, Surgical oncology, General surgery, Internal medicine, Gastroenterology, Medicine, Hepatology, business, Small intestine, Colorectal surgery, Abdominal surgery
Published
1968

Catalog

Books, media, physical & digital resources
See catalog results